Drug survival rate of dupilumab in Japanese patients with atopic dermatitis

類似資料

• Long-term effectiveness and safety of upadacitinib for Japanese patients with moderate-to-severe atopic dermatitis: a real-world clinical study
  著者:: Teppei Hagino, 等
  出版事項: (2024-12-01)
• Japanese Guideline for Atopic Dermatitis 2014
  著者:: Ichiro Katayama, 等
  出版事項: (2014-01-01)
• The differential effects of upadacitinib treatment on skin rashes of four anatomical sites in patients with atopic dermatitis
  著者:: Teppei Hagino, 等
  出版事項: (2023-12-01)
• Predictive factors for responders to upadacitinib treatment in patients with atopic dermatitis
  著者:: Teppei Hagino, 等
  出版事項: (2024-12-01)
• Real-world safety and effectiveness of dupilumab for the treatment of atopic dermatitis: two-year post-marketing surveillance in Japan
  著者:: Hidehisa Saeki, 等
  出版事項: (2025-07-01)